2nd Annual Clinical Data Management Innovation 2024

Bringing together clinical data managers for fresh insight and hot technologies impacting US clinical trials

10 - 11

September

2024
  • Hyatt Regency San Francisco Airport, San Francisco, USA
  • Ticketed
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Sponsors
  • Media Centre
  • Event Gallery
  • Why partner?
  • Contact Us
close

Why attend?

A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

Engaging keynote presentations from industry luminaries, panel discussions featuring perspectives from diverse stakeholders, networking sessions to connect with peers and experts, exhibition area showcasing innovative solutions and technologies, opportunities to interact with FDA representatives and regulatory experts.

The programme will feature a range of speakers from the likes of FDA, Gilead Sciences, Eli Lilly and Company, Takeda, Genentech Roche Group, and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

Agenda

  • 10 Sep 2024
  • 11 Sep 2024
Expand All

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

9 AM

PANEL: Navigating the learning curve – staying current, automation adoption, and innovating in technologies

  • Discussing the importance of fostering a culture of continuous learning within organizations
  • Sharing insights on successful approaches for transitioning from manual practices to automated workflows in analytics
  • Discussing the advantages of collaborative learning through team-based projects and knowledge sharing sessions
  • Exploring strategies for fostering a culture where team members are encouraged to think creatively and propose innovative solutions
  • Highlighting the importance of professional networks and industry collaborations for staying informed and sharing insights

Moderator
Joshua Cox, Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

Panelists
Hyunjae Ryan Kim, Associate Director, Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences
Prasun Mishra, Chief Executive Officer, Agility Pharma
Kimberly Barnholt, Executive Director, Evidence Generation, Genentech

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company
Hyunjae Ryan Kim
Associate Director, Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences
Prasun Mishra
Chief Executive Officer, Agility Pharmaceuticals
Kimberly Barnholt
Executive Director, Evidence Generation, Genentech, Roche Group

9:30 AM

Reserved for event sponsor

10 AM

Unveiling use cases: harnessing synthetic data creation with machine learning

  • Shedding light on diverse use cases where organizations leverage synthetic data to unlock innovation and overcome data limitations
  • Employing models that evolve and learn from real data, ensuring a dynamic and realistic synthetic data generation process
  • Crafting synthetic patient data sets to simulate diverse medical conditions, optimizing precision medicine trial designs
  • Demonstrating how organizations navigate data privacy concerns by using synthetic healthcare data that complies with regulations

Speakers

Satha Thillaiampalam
Associate VP, Biostatistics and Statistical Programming Process and Infrastructure, Loxo Oncology Inc

10:30 AM

Morning refreshments and networking

11:15 AM

Unlocking the potential of metadata repositories in small-scale clinical trials

  • Empowering small-scale trials through enhanced data organisation and integrity
  • Addressing the challenges of diverse industry standards
  • Strategies to seamlessly adapt to evolving study requirements

Speakers

Aroba Hafeez
Director, Clinical Data Management, Asher Biotherapeutics

11:45 AM

Reserved for event sponsor

12:15 PM

Modernizing data integrity: Leveraging analytics for quality data capture beyond traditional edit checks

  • Implementing advanced analytics techniques for enhancing data integrity beyond conventional edit checks
  • Exploring strategies to modernize data capture methods for improved quality assurance
  • Leveraging analytics tools to identify anomalies and ensure data accuracy throughout the clinical trial process

Speakers

Alan Chang
Executive Director, Medical Affairs Strategy & Informatics, Allakos

12:45 PM

Reserved for technology spotlight sponsor

1 PM

Lunch and networking

2 PM

Unveiling innovations in automated data cleaning

  • Utilizing automated algorithms to identify and remove duplicate record, ensuring data accuracy
  • Applying automated rule engines to validate data for authenticity and integrity
  • Using machine learning for predicting potential data errors and proactively addressing them

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

2:30 PM

Reserved for event sponsor

3 PM

Unleashing the power of digital protocols and automated study designs in clinical research

  • Navigating the paradigm shift towards digital protocols and data flow in clinical research
  • Exploring dynamic, digital protocols that adapt based on real-time data, fostering agility in study conduct
  • Utilizing integrated digital platforms for smooth and secure data flow, minimizing manual interventions
  • Leveraging digital tools for iterative study design, incorporating real-world insights during the planning phase
  • Implementing protocols designed for study reuse with molecular components, reducing redundancy and accelerating study startup

Speakers

Jonathan Chainey
Global Head, Data Standards, PD Data Sciences, Genentech, part of Roche

3:30 PM

Afternoon refreshments and networking

4 PM

Exploring automation from manual processes in order to focus on the discovery of actionable insights from the data

  • Automation of raw data ingestion with metadata management to intelligently pick the most optimal analytics pipelines to generate comprehensive results.
  • Establishing a collaborative platform to develop and standardize bioinformatics analysis pipelines
  • Standardizing and harmonizing the comprehensive results for exploratory analytics
  • Working on incorporating AI/ML technologies, such as data augmentation and combining LLM and KG, into practices

Speakers

Hyunjae Ryan Kim
Associate Director, Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences

4:30 PM

Reserved for event sponsor

5 PM

PANEL: Aligning expectations with today’s data managers: redefining the Data Manager’s role

  • Navigating the changing dynamics in data management and the imperative to align expectations with the capabilities of today’s data managers
  • Recognizing the evolution towards strategic roles, including data governance, compliance, and leveraging advanced technologies
  • Embracing individuals with proficiency in emerging technologies, including data analytics, machine learning, and cloud computing
  • Emphasizing the importance of effective communication and collaboration between data mangers and stakeholders
  • Advocating for ongoing training and professional development to keep data managers abreast of latest technologies and best practices

Moderator
Joshua Cox, Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

Panelists
Tony Hung, Director, Clinical Data Management, Denali Therapeutics
Shridhar Munichandrappa, Senior Director Data Management, Recursion
Bao Dinh, Associate Director, Vendor Engagement & Business Operations, CDM, Takeda

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company
Tony Hung
Director, Clinical Data Management, Denali Therapeutics
Shridhar Munichandrappa
Senior Director Data Management, Recursion
Bao Dinh
Associate Director, Vendor Engagement & Business Operations, CDM, Takeda

5:30 PM

Chairperson’s closing remarks

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

END OF DAY 1 AND NETWORKING DRINKS

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

9 AM

Navigating regulatory landscape in AI-driven data usage and generation

  • Exploring the evolving regulatory landscape surrounding the integration of AI in generating and utilizing clinical data
  • Analyzing FDA’s guidance on the use of AI in clinical trials and medical devices
  • Discuss regulatory expectations for maintaining data accuracy and integrity in AI-driven processes
  • Addressing the requirements of HIPAA when handling patient data
  • FDA’s software participation program: understanding the FDA’s approach to recertifying AI software developers and its impact on validation requirements
  • FDA’s RWE framework: exploring how real-world evidence generated by AI can contribute to regulatory decision-making
  • Featuring examples of AI applications in clinical data that successfully navigated regulatory processes

Speakers

Dan Solis
Assistant Commissioner for Import Operations, FDA

9:30 AM

Reserved for event sponsor

10 AM

Fostering trust through good data stewardship: building relationships with research participants

  • Defining the concept of data stewardship within the context of clinical research
  • Exploring strategies for implementing robust security measures to safeguard participant data throughout its lifecycle, from collection to dissemination
  • Fostering participant community understanding of de-identification and emphasizing the societal good that may result from future use and sharing of clinical trial data

Speakers

Edward Kuczynski
Director, Human Research Protection Program, UCSF

10:30 AM

Morning refreshments and networking

11:15 AM

Discovering the power of open-source technology in clinical data management strategy

  • Delving into the benefits, challenges, and strategic considerations of adopting open-source solutions in the clinical research domain
  • Overview of open-source EDC systems for efficient and flexible data collection
  • Discussing how open-source solutions can significantly reduce software licensing costs
  • Exploring strategies to ensure data security and compliance with regulatory standards when using open-source solutions

Speakers

Harit Nandani
Director, Clinical Data Management, GRAIL

11:45 AM

Reserved for event sponsor

12:15 PM

Harnessing AI/ML for seamless clinical data lifecycle management

  • Streamlining processes form data inception to submission for faster and more efficient trials
  • Enhancing data collection through real-time monitoring, adaptive forms, and predictive analytics for improved data quality
  • Accelerating data tabulation with automated extraction, transformation, and loading (ETL) processes, reducing manual efforts
  • Navigating compliance requirements for data submission through intelligent automation

Speakers

Prasun Mishra
Chief Executive Officer, Agility Pharmaceuticals

12:45 PM

Lunch, networking and prize draw!

1:35 PM

EXHIBITION APPLE PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall and you will need to be physically present to be eligible for a prize. Make sure you don’t miss out!

1:45 PM

Problem-Solving Roundtable Discussions

During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical data management. After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1:
Uncovering ways of establishing standards for clinical data sharing that enable decentralized or digital trials
Sharon Rittenhouse, Senior Director, Clinical Data Management & Data Science, Edwards Lifesciences

ROUNDTABLE 2:
Managing clinical data collection and verification strategies as EDC becomes minimized while DDC and eCOA solutions continue to grow
Megan L. Dunham, Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

ROUNDTABLE 3
Discussing the critical and evolving role of standards
Jonathan Chainey, Global Head, Data Standards, PD Biometrics, Genentech, Roche Group

ROUNDTABLE 4
Managing the growth in data sources for clinical trials
Binitha Prasad, Director, Clinical Data Management, Jazz Pharmaceuticals

Speakers

Sharon Rittenhouse
Senior Director, Clinical Data Management & Data Science, Edwards Lifesciences
Megan L. Dunham
Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals
Jonathan Chainey
Global Head, Data Standards, PD Data Sciences, Genentech, part of Roche
Binitha Prasad
Director, Clinical Data Management Jazz Pharmaceuticals

3:15 PM

Close of conference

End Of Conference

ADDITIONAL TOPICS

Balancing speed and quality in drug development – accelerating market entry with efficient data strategies

  • Exploring strategies to leverage data more efficiently, accelerating the development timeline while maintaining robust safety and quality measures
  • Incorporating advanced analytics for real-time data insights, enabling safer decision-making in the development pipeline
  • Leveraging collaborative data platforms to facilitate information sharing among research teams, enhancing synergy and reducing redundancy
  • Integrating diverse datasets, from preclinical to clinical phases, for a holistic understanding of drug development trajectories
  • Addressing concerns related to data security and privacy through robust encryption and compliance with regulatory standards

Revolutionizing data management for small and mid-sized sponsor companies through risk-based quality management

  • Adapting monitoring frequency based on risk assessment to optimize resource allocation
  • Applying risk assessment to determine the extent and frequency of data verification activities
  • Focusing verification efforts on critical data points, reducing the burden on resources
  • Strategies to optimize RBQM processes within the limitations of small and mid-sized companies

Discovering the power of open-source technology in clinical data management strategy

  • Delving into the benefits, challenges, and strategic considerations of adopting open-source solutions in the clinical research domain
  • Overview of open-source EDC systems for efficient and flexible data collection
  • Discussing how open-source solutions can significantly reduce software licensing costs
  • Exploring strategies to ensure data security and compliance with regulatory standards when using open-source solutions

Speakers

Select a speaker to learn more

Back
Joshua Cox
Vice President, Clinical Data & Analytics Capabilities, Eli Lilly and Company

Joshua Cox has been honing his data management expertise in the drug development industry for nearly 20 years.  After breaking into the industry and gaining exposure to diverse therapeutic areas and development approaches with a CRO, Joshua has focused the last 15-years in sponsor driven early phase oncology.  He has enjoyed opportunities with bio-tech start-ups as well as established big pharma companies, each engagement adding valuable knowledge and experience to his skillset.  Joshua has led the development of data management departments by conceiving and implementing fit for purpose and results-driven technologies and processes always with an eye toward innovation and efficiency.  Now pursuing leadership opportunities outside the confines of traditional data management, Joshua is eager and excited to be a part of teams pursuing novel solutions to known challenges as well as employing cutting edge strategies and technologies to elevate the already high standards we expect and ultimately get the best medicines to the patients in need.

Session Details:

Chairperson’s opening remarks

2024-09-11, 8:50 AM

Session Details:

Chairperson’s opening remarks

2024-09-10, 8:50 AM

Session Details:

PANEL: Navigating the learning curve – staying current, automation adoption, and innovating in technologies

2024-09-10, 9:00 AM

Session Details:

Unveiling innovations in automated data cleaning

2024-09-10, 2:00 PM

Session Details:

Chairperson’s closing remarks

2024-09-10, 5:30 PM

Session Details:

PANEL: Aligning expectations with today’s data managers: redefining the Data Manager’s role

2024-09-10, 5:00 PM

View In Agenda
Next speaker
Back
Dan Solis
Assistant Commissioner for Import Operations, FDA

Dan Solis is a recognized expert in FDA import operations and is the Assistant Commissioner for ORA’s Office of Import Operations. Prior to this position he was the Division Director for the Division of West Coast Imports since February 9, 2018. He started his career with FDA in 1998. Prior to working in FDA, Mr. Solis worked in the Bioresearch field focusing on Medical Device and Drug Application Products after graduating from the University California of Irvine and the University of La Verne. Mr. Solis has held many positions within FDA that includes working at the FDA lab in Irvine, Ca. as a Microbiologist, HQ position within the Division of Import Operations in Rockville, MD, working as an Import Compliance Officer and working in the FDA Los Angeles District Office as a Director of Import Operations Branch.

Session Details:

Navigating regulatory landscape in AI-driven data usage and generation

2024-09-11, 9:00 AM

View In Agenda
Next speaker
Back
Jonathan Chainey
Global Head, Data Standards, PD Data Sciences, Genentech, part of Roche

Jonathan Chainey is an Executive Director and Global Head, Data Standards & Governance within Data Sciences, Product Development at Roche. He leads a global team accountable for the cross-functional governance and adoption of Roche’s CDISC-aligned global data standards across all Roche sponsored early & late phase clinical trials.  He is currently serving on CDISC’s board of directors and is chair of CDISC’s Technical Advisory Committee.

Over the past 25 years Jonathan has worked within the biopharmaceutical industry in the U.K., Switzerland, and United States. in a range of disciplines including pre-clinical pharmacological research (Ciba-Geigy), clinical data management (Parexel), statistical programming & analysis (Pfizer, Novartis), applications development (Pfizer, Roche), and process analysis, data standards & governance (Roche).

Jonathan has a scientific background and education including a BSc (Hons) Pharmacology, University of Bath, U.K. He is a British citizen and currently located in the San Francisco Bay Area, California.

Session Details:

Problem-Solving Roundtable Discussions

2024-09-11, 1:45 PM

Session Details:

Unleashing the power of digital protocols and automated study designs in clinical research

2024-09-10, 3:00 PM

View In Agenda
Next speaker
Back
Hyunjae Ryan Kim
Associate Director, Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences

Dr. Hyunjae Ryan Kim is currently the leader of a team at Gilead Sciences, which specializes in oncology genomics analytics. He is responsible for developing multimodal AI algorithms and applications used in clinical development for oncology. Additionally, he researches how to improve cancer treatment using deep learning and multi-omics data integration by modulating tumor microenvironments.

 

Dr. Kim previously held the associate director of pediatric oncology bioinformatics position at the Texas Children’s Cancer Center at Baylor College of Medicine (BCM). Before joining BCM, he was a senior computational biologist at the Memorial Sloan Kettering Cancer Center. Dr. Kim and his team developed routine genomic profiling systems (MSK-IMPACT) and matching treatment options for all patients in MSKCC. He also served as research faculty at the Rockefeller University, where he built systems to decipher epigenetic codes and transcriptional controls from multi-omics data with C. David Allis and Thomas Tuschl. Dr. Kim completed his postdoctoral training in Systems Biology at Columbia University Medical Center.

Session Details:

PANEL: Navigating the learning curve – staying current, automation adoption, and innovating in technologies

2024-09-10, 9:00 AM

Session Details:

Exploring automation from manual processes in order to focus on the discovery of actionable insights from the data

2024-09-10, 4:00 PM

View In Agenda
Next speaker
Back
Tony Hung
Director, Clinical Data Management, Denali Therapeutics

I started my career at Everest Clinical Research in CDM. I later joined Gilead's CDM team focusing on infectious disease therapeutic area. I transitioned to commercial (sales analytics) for almost 3 years to better understand the lifecycle of drug post approval. I decided to return to CDM and joined Biomarin to better understand rare diseases. Post Biomarin, I spent some time at Nektar before landing the position at Denali, focusing on rare disease trials again.

Session Details:

PANEL: Aligning expectations with today’s data managers: redefining the Data Manager’s role

2024-09-10, 5:00 PM

View In Agenda
Next speaker
Back
Bao Dinh
Associate Director, Vendor Engagement & Business Operations, CDM, Takeda

Session Details:

PANEL: Aligning expectations with today’s data managers: redefining the Data Manager’s role

2024-09-10, 5:00 PM

View In Agenda
Next speaker
Back
Aroba Hafeez
Director, Clinical Data Management, Asher Biotherapeutics

Session Details:

Unlocking the potential of metadata repositories in small-scale clinical trials

2024-09-10, 11:15 AM

View In Agenda
Next speaker
Back
Kimberly Barnholt
Executive Director, Evidence Generation, Genentech, Roche Group

Kimberly Barnholt has been a healthcare leader in various roles spanning from academic research, to disruptive start-up, to global pharmaceutical company. In all roles, she has focused on bridging science, data, and operational disciplines to challenge the status quo and transform how we can deliver more impact for our patients. At Genentech, she has served as a Program Leader for cross-industry collaborations and cross-R&D data ecosystem transformation. Currently, Dr. Barnholt is leading an Evidence Generation team of data strategists and clinical innovation and technology leaders to integrate new approaches to clinical trials.

Session Details:

PANEL: Navigating the learning curve – staying current, automation adoption, and innovating in technologies

2024-09-10, 9:00 AM

View In Agenda
Next speaker
Back
Shridhar Munichandrappa
Senior Director Data Management, Recursion

Session Details:

PANEL: Aligning expectations with today’s data managers: redefining the Data Manager’s role

2024-09-10, 5:00 PM

View In Agenda
Next speaker
Back
Binitha Prasad
Director, Clinical Data Management Jazz Pharmaceuticals

Session Details:

Problem-Solving Roundtable Discussions

2024-09-11, 1:45 PM

View In Agenda
Next speaker
Back
Edward Kuczynski
Director, Human Research Protection Program, UCSF

Edward joined the UCSF Office of Research as its Director of the Human Research Protection Program (HRPP) in May 2020. In this role, he oversees the UCSF HRPP, which is comprised of the Institutional Review Board (IRB) and its committees, the Quality Improvement Unit, and the Human Gamete, Embryo and Stem Cell Research (GESCR) Committee. Edward has a background in strategic planning and business plan implementation for clinical research activities; experience building and directing clinical and research programs at Academic Medical Centers; and familiarity with creating de novo core clinical research support services. He has served as co-investigator on the NIH Clinical Network for Contraceptive Research grant, clinical site investigator for an NIH-funded grant studying Antiphospholipid Pregnancy Loss, and co-investigator on a March of Dimes program grant on risk factors for prematurity. More recently, Edward was a Strategic Advisor for Clinical and Translational Research Programs at the Stanford University Center for Clinical & Translational Research & Education. He has also served as the Director of Clinical Research Operations for the Tufts Clinical and Translational Science Institute, a consult lead for the Johns Hopkins University/Tufts University Trial Innovation Center, as well as an Assistant Professor in the Department of Medicine at Tufts University School of Medicine.

Session Details:

Fostering trust through good data stewardship: building relationships with research participants

2024-09-11, 10:00 AM

View In Agenda
Next speaker
Back
Satha Thillaiampalam
Associate VP, Biostatistics and Statistical Programming Process and Infrastructure, Loxo Oncology Inc

Satha Thillaiampalam has been leading various responsibilities within the biopharmaceutical industry. Throughout his twenty-year career as a Biostatistician and Statistical Programmer, he has led numerous strategic initiatives involving cross functional teams to continuously improve systems, processes, and governance. In his current role, he leads the processes and infrastructure activities for oncology biostatistics department within Lilly. His key interests are optimizing operational efficiency and developing high performing systems by leveraging advancements in technology and standards.

Session Details:

Unveiling use cases: harnessing synthetic data creation with machine learning

2024-09-10, 10:00 AM

View In Agenda
Next speaker
Back
Prasun Mishra
Chief Executive Officer, Agility Pharmaceuticals

Dr Mishra (Ex Genentech, Ex NCI, Ex NIH) is the founding president and CEO of the American Association for Precision Medicine ( and chair of ACT AAPM’s Coronavirus Taskforce He is leading research efforts focused on preventing curing chronic diseases not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company committed to revolutionizing drug discovery development through technology, big data, robotics, and artificial intelligence He is a serial entrepreneur who founded his first company after graduating high school, and his second company during his Ph D Since then, he has accumulated a wealth of experience by building, investing, and advising numerous other companies He is an investor, co founder/ board member of a few corporations, focused on accelerating drug discovery/ development, data analytics, robotics, mental health, and digital health He is also the founder of AAPM Angels and Investors AAi an investment group focused on investing in drug discovery, diagnostics, precision medicine, technology healthcare companies He is also the founding investor and advisor to Barcelona Ventures and serves as an advisor to a 100 M private equity fund Widely recognized as a thought leader in the field of ‘technology and healthcare’, Dr Mishra has keynoted, chaired, curated, and organized numerous successful international conferences He served as a Scientist and Principal Investigator at the pharma giant Genentech, Roche Where he participated in several drug discovery project teams Moreover, his passion for drug development and precision medicine has led to the identification of new drug targets, biomarkers, companion diagnostics, and several drugs/ combinations in the clinic His research work has been recognized globally by over 40 prestigious awards and honors Due to his unique perspective selfless service, he is a highly respected sought after mentor to many The companies that he has advised have raised multimillion dollars Notably, he serves as a mentor and advisor to several VC funds and startup accelerators, including IndieBio HIMSS/Health 2 0 ’s Project Zygote, MedLabs ZGC Capital, J&J JLabs UCSF Innovation Venture, UCSF Invent Fund, and California Life Sciences’s FAST program, to help grow California’s life sciences innovation ecosystem

Session Details:

PANEL: Navigating the learning curve – staying current, automation adoption, and innovating in technologies

2024-09-10, 9:00 AM

Session Details:

Harnessing AI/ML for seamless clinical data lifecycle management

2024-09-11, 12:15 PM

View In Agenda
Next speaker
Back
Alan Chang
Executive Director, Medical Affairs Strategy & Informatics, Allakos

Session Details:

Modernizing data integrity: Leveraging analytics for quality data capture beyond traditional edit checks

2024-09-10, 12:15 PM

View In Agenda
Next speaker
Back
Harit Nandani
Director, Clinical Data Management, GRAIL

Harit Nandani has 12+ years of experience in clinical trials data and technology leadership for both diagnostics and therapeutic trials. He specializes in clinical trial data management and analysis, configuring systems for population-scale studies, and using analytics tools to monitor projects. Currently, he is the Director of Clinical Data Management at GRAIL, overseeing data and systems for trials in the UK and US supporting early cancer detection diagnostics development. He has worked on projects enrolling over 300,000 participants, leading to the development of the Galleri test, which has detected over 50 types of cancer and has been named one of TIME Magazine's best inventions and The Atlantic's 10 most promising breakthroughs of 2022. Prior to GRAIL, Harit led late-stage pivotal trials in Oncology at Gilead Sciences and worked in various clinical research roles at a CRO and a small biopharmaceutical development company.

Session Details:

Discovering the power of open-source technology in clinical data management strategy

2024-09-11, 11:15 AM

View In Agenda
Next speaker
Back
Megan L. Dunham
Associate Director, Clinical Data Innovation, Jazz Pharmaceuticals

Session Details:

Problem-Solving Roundtable Discussions

2024-09-11, 1:45 PM

View In Agenda
Next speaker
Back
Sharon Rittenhouse
Senior Director, Clinical Data Management & Data Science, Edwards Lifesciences

Session Details:

Problem-Solving Roundtable Discussions

2024-09-11, 1:45 PM

View In Agenda
Next speaker

Plan Your Visit

Venue

Hyatt Regency San Francisco Airport

1333 Old Bayshore Hwy Burlingame CA 94010 United States

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

Sponsors

Select a sponsor to learn more

Featured Sponsor

Session Sponsors

Technology spotlight Sponsor

Exhibitors

Why partner?

 

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 150+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

MEDIA PARTNERS

Become A Media Partner

 A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

The programme will feature a range of speakers from the likes of Bristol Myers Squib, Otsuka, Cerevel Therapeutics, Merck, Daiichi Sankyo and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Ben Lloyd-Davies

Head of Healthcare Sales

+44 (0)20 7936 6948

SPEAKER ENQUIRIES

Ralitsa Pashkuleva

Programme Director

+44 (0)20 7947 2917

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact

Ben Lloyd-Davies

Head of Healthcare Sales


+44 (0)20 7936 6948

SPEAKER ENQUIRES

To enquire about speaking opportunities for the conference, please contact:

Ralitsa Pashkuleva

Programme Director


+44 (0)20 7947 2917